213
Views
20
CrossRef citations to date
0
Altmetric
Research Article

Pharmacophore modeling, molecular docking and molecular dynamics studies on natural products database to discover novel skeleton as non-purine xanthine oxidase inhibitors

, , , , &
Pages 246-255 | Received 22 Apr 2018, Accepted 10 May 2018, Published online: 29 May 2018

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Li-Peng Li, Hao-Xin Li, Hui Zhou, Wei-Ya Li, Run-Ling Wang, Ying-Chi Zhang & Ying Ma. (2023) Exploring the mechanism of C473D mutation on CDC25B causing weak binding affinity with CDK2/CyclinA by molecular dynamics study. Journal of Biomolecular Structure and Dynamics 41:22, pages 12552-12564.
Read now
Abhisek Jana, Rahul Naga, Sougata Saha, Christian Griñán-Ferré & Deb Ranjan Banerjee. (2023) Integration of ligand and structure-based pharmacophore screening for the identification of novel natural leads against Euchromatic histone lysine methyltransferase 2 (EHMT2/G9a). Journal of Biomolecular Structure and Dynamics 0:0, pages 1-28.
Read now
Khedidja Benarous, Leila Bou-Salah, Abderrahmane Linani, Mohamed Yousfi, Irena Kostova & Luciano Saso. (2022) Lanthanide (III) complexes of bis-coumarins as strong inhibitors of bovine xanthine oxidase - molecular docking and SAR studies. Journal of Biomolecular Structure and Dynamics 40:6, pages 2733-2739.
Read now

Articles from other publishers (17)

Ana P. C. César, Francisco E. S. Lopes, Francisca F. N. Azevedo, Yago O. Pinto, Claudia R. Andrade, Felipe P. Mesquita, Gabrielly O. Silva, Cleverson D. T. Freitas & Pedro F. N. Souza. (2023) Antioxidant peptides from plants: a review. Phytochemistry Reviews.
Crossref
Yuting Wang, Hai Zhang, Jindong Li, Miao-Miao Niu, Yang Zhou & Yuanqian Qu. (2022) Discovery of potent and noncovalent KRASG12D inhibitors: Structure-based virtual screening and biological evaluation. Frontiers in Pharmacology 13.
Crossref
Guowen Zhang, Miao Zhu, Yijing Liao, Deming Gong & Xing Hu. (2022) Action mechanisms of two key xanthine oxidase inhibitors in tea polyphenols and their combined effect with allopurinol. Journal of the Science of Food and Agriculture 102:15, pages 7195-7208.
Crossref
Navvabeh Salarizadeh, Mohammad Reza Aallaei, Ali Zarei, Rahime Eshaghi Malekshah, Elaheh Molaakbari & Amirreza Farajnezhadi. (2022) Docking and Molecular Dynamics Simulations of Flavonoids as Inhibitors of Infectious Agents: Rutin as a Coronavirus Protease Inhibitor. ChemistrySelect 7:37.
Crossref
Ting-Ting Ding, Ya-Ya Liu, Li-Ming Zhang, Jia-Rui Shi, Wei-Ren Xu, Shao-Yong Li & Xian-Chao Cheng. (2022) Exploring Dual Agonists for PPARα/γ Receptors using Pharmacophore Modeling, Docking Analysis and Molecule Dynamics Simulation. Combinatorial Chemistry & High Throughput Screening 25:9, pages 1450-1461.
Crossref
Na Zhai, Yanming Chen, Chenchen Wang, Fengshou Wu, Xiaogang Luo, Xiulian Ju, Hui Liu & Genyan Liu. (2022) A multiscale screening strategy for the identification of novel xanthine oxidase inhibitors based on the pharmacological features of febuxostat analogues. New Journal of Chemistry 46:14, pages 6549-6559.
Crossref
Leila Bou-Salah, Khedidja Benarous, Abderahmane Linani, Faiza Rabhi, Kheira Chaib, Imane Chine, Hadjer Bensaidane & Mohamed Yousfi. (2021) Anti-inflammatory drugs as new inhibitors to xanthine oxidase: In vitro and in silico approach. Molecular and Cellular Probes 58, pages 101733.
Crossref
Na Zhai, Chenchen Wang, Fengshou Wu, Liwei Xiong, Xiaogang Luo, Xiulian Ju & Genyan Liu. (2021) Exploration of Novel Xanthine Oxidase Inhibitors Based on 1,6-Dihydropyrimidine-5-Carboxylic Acids by an Integrated in Silico Study. International Journal of Molecular Sciences 22:15, pages 8122.
Crossref
Shahrukh Qureshi, Ravina Khandelwal, Maddala Madhavi, Naveesha Khurana, Neha Gupta, Saurav K. Choudhary, Revathy A. Suresh, Lima Hazarika, Chillamcherla D. Srija, Khushboo Sharma, Mali R. Hindala, Tajamul Hussain, Anuraj Nayarisseri & Sanjeev K. Singh. (2021) A Multi-target Drug Designing for BTK, MMP9, Proteasome and TAK1 for the Clinical Treatment of Mantle Cell Lymphoma. Current Topics in Medicinal Chemistry 21:9, pages 790-818.
Crossref
Wolfgang Sippl & Fidele Ntie-Kang. (2021) Editorial to Special Issue—“Structure-Activity Relationships (SAR) of Natural Products”. Molecules 26:2, pages 250.
Crossref
Ting Xin, Wei Lv, Dongmei Liu, Yongle Jing & Fang Hu. (2020) Opa1 Reduces Hypoxia-Induced Cardiomyocyte Death by Improving Mitochondrial Quality Control. Frontiers in Cell and Developmental Biology 8.
Crossref
Jin Wang, Sam Toan & Hao Zhou. (2020) New insights into the role of mitochondria in cardiac microvascular ischemia/reperfusion injury. Angiogenesis 23:3, pages 299-314.
Crossref
Elsafira Ariavianti, Filia Stephanie & Usman Sumo Friend Tambunan. (2020) Virtual Screening Based on Pharmacophore to Discover Host ER Alpha-Glucosidase II Inhibitor for Dengue Therapy. Key Engineering Materials 840, pages 221-229.
Crossref
Ting Xin & Chengzhi Lu. (2020) Irisin activates Opa1-induced mitophagy to protect cardiomyocytes against apoptosis following myocardial infarction. Aging 12:5, pages 4474-4488.
Crossref
Mukta Sharma, Anupama Mittal, Aarti Singh, Ashwin K Jainarayanan, Swapnil Sharma & Sarvesh Paliwal. (2020) Pharmacophore-driven identification of N-methyl-D-receptor antagonists as potent neuroprotective agents validated using in vivo studies. Biology Methods and Protocols 5:1.
Crossref
Katarina Tomovic, Budimir S. Ilic, Zaklina Smelcerovic, Marija Miljkovic, Denitsa Yancheva, Milan Kojic, Anelia Ts Mavrova, Gordana Kocic & Andrija Smelcerovic. (2020) Benzimidazole-based dual dipeptidyl peptidase-4 and xanthine oxidase inhibitors. Chemico-Biological Interactions 315, pages 108873.
Crossref
Yeheng Zhou, Jiale Peng, Penghua Li, Haibo Du, Yaping Li, Yingying Li, Li Zhang, Wei Sun, Xingyong Liu & Zhili Zuo. (2019) Discovery of novel indoleamine 2,3-dioxygenase 1 (IDO1) inhibitors by virtual screening. Computational Biology and Chemistry 78, pages 306-316.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.